STOCK TITAN
  1. Home
  2. News
  3. MDT

Medtronic plc - MDT STOCK NEWS

Welcome to our dedicated page for Medtronic plc news (Ticker: MDT), a resource for investors and traders seeking the latest updates and insights on Medtronic plc stock.

Medtronic plc (NYSE: MDT) is an American medical device company with its operational and executive headquarters in Minneapolis, Minnesota, and legal headquarters in Dublin, Ireland, following its acquisition of Covidien in 2015. As one of the largest medical-device companies globally, Medtronic specializes in developing and manufacturing therapeutic medical devices for chronic diseases.

The company’s extensive product portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. It markets these products to healthcare institutions and physicians worldwide, with international sales accounting for approximately 50% of its total revenue.

In a recent announcement on April 10, 2024, Medtronic unveiled significant advancements in artificial intelligence (AI) for endoscopic care through the launch of ColonPRO™ software for the GI Genius™ intelligent endoscopy system. This new software improves polyp detection and introduces procedural highlights to enhance physicians' workflow. The company has also entered into a collaboration with Modernizing Medicine® to integrate AI-driven data with electronic health records (EHR).

Medtronic recently reported its financial results for the fourth quarter and fiscal year 2024, showcasing a global revenue of $32.364 billion, a 3.6% increase compared to the previous year. The company's revenue growth was fueled by advancements in its Cardiovascular, Neuroscience, Medical Surgical, and Diabetes portfolios.

In addition to its financial performance, Medtronic has made strides in technological innovation. The U.S. FDA approved the Inceptiv™ closed-loop rechargeable spinal cord stimulator (SCS) for chronic pain treatment, demonstrating the company’s commitment to addressing unmet clinical needs and improving patient care through advanced technologies.

Medtronic remains dedicated to its mission of alleviating pain, restoring health, and extending life, driven by a global team of over 95,000 employees across 150 countries. The company continues to leverage its diverse knowledge and insatiable curiosity to deliver innovative solutions that transform lives. For more information, visit Medtronic's official website.

News

Medtronic receives CE Mark for its next generation Micra leadless pacing systems

Rhea-AI Summary
Medtronic plc (MDT) has received CE Mark for its Micra™ AV2 and Micra™ VR2, the next generation of its miniature, leadless pacemakers. The new pacemakers offer 40% more battery life, projecting a battery life of nearly 16 and 17 years, respectively. Additionally, they are the world's smallest pacemakers and the only leadless pacemakers with remote monitoring capabilities, providing significant benefits to patients. Medtronic's legacy in cardiac pacing includes several groundbreaking innovations, positioning the company as a leader in the industry.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.76%
Tags
none
-
News

Hypertension Control Program Aims to Tackle Major Driver of Health Disparities for Black Americans

Rhea-AI Summary
Association of Black Cardiologists (ABC) announced the launch of its Hypertension Control Program, offering 50 member clinicians the opportunity to receive American Hypertension Specialist Certification. The program aims to improve cardiovascular health outcomes for Black patients, who are disproportionately impacted by hypertension. Medtronic is sponsoring the program and providing support for clinicians to receive certification.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.19%
Tags
none
-
News

Medtronic Chairman and CEO Geoff Martha to speak at J.P. Morgan healthcare conference

Rhea-AI Summary
Medtronic plc (NYSE:MDT) to participate in the 42nd annual J.P. Morgan healthcare conference. Geoff Martha, Chairman and CEO, will make a formal presentation and answer questions on January 8, 2024. A live webcast of the presentation and Q&A session will be available on the company's investor relations webpage.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.19%
Tags
conferences
News

Medtronic Continues To Rank in the DJSI World Index for 2023

Rhea-AI Summary
Medtronic plc (MDT) continues to be included in the Dow Jones Sustainability World Index (DJSI) as one of the world's leading companies for sustainability, based on their strong environmental, social, and governance (ESG) management and performance. The company's FY2023 Sustainability Report highlights progress on ESG targets, including revenue from new products, patient access, inclusion, diversity, equity, responsible supply management, climate risk and resilience, and patient safety and product quality.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.98%
Tags
none
-
News

Medtronic creates history with FDA approval of its novel PulseSelect™ Pulsed Field Ablation System to treat atrial fibrillation

Rhea-AI Summary
Medtronic plc (NYSE: MDT) has received FDA approval for the PulseSelect Pulsed Field Ablation (PFA) System for the treatment of both paroxysmal and persistent atrial fibrillation. The system is the first of its kind to receive FDA approval and boasts excellent safety, efficacy, and efficiency. The PulseSelect PFA system is designed to provide rapid, effective pulmonary vein isolation (PVI) and is supported by the PULSED AF study, showing a 0.7% safety event rate and clinical success rates of 80% in both paroxysmal and persistent AF patients. The system also includes differentiated safety features, built-in safety measures, and a small, maneuverable catheter, making it a significant advancement in AF ablation technology.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.87%
Tags
fda approval
-
News

Medtronic and Cosmo Pharmaceuticals forge ahead in AI-driven care

Rhea-AI Summary
Medtronic plc (NYSE: MDT) expands partnership with Cosmo Pharmaceuticals to revolutionize endoscopy with cutting-edge AI technology. The agreement includes a $100 million upfront payment, double-digit royalties on net sales, and potential milestone payments of $100 million by 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.47%
Tags
AI
News

Medtronic announces cash dividend for third quarter of fiscal year 2024

Rhea-AI Summary
Medtronic plc (NYSE:MDT) approved a cash dividend of $0.69 per ordinary share for the third quarter of fiscal year 2024. The company has consistently increased its annual dividend payment for the past 46 years and is a constituent of the S&P 500 Dividend Aristocrats index. The dividend is payable on January 12, 2024, to shareholders of record at the close of business on December 20, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.25%
Tags
dividends earnings
-
News

Medtronic LABS: The Vital Role Of Community Health Workers

Rhea-AI Summary
Medtronic (MDT) focuses on reducing health disparities in a meaningful, sustainable, and scalable way
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.18%
Tags
none
-
News

Medtronic LABS: Opening Up Software To Expand Access to Healthcare

Rhea-AI Summary
Medtronic LABS (MDT) makes its digital health platform SPICE open source, accelerating access to healthcare in underserved communities. Since 2013, the nonprofit has enrolled over 217,000 people in one million patients healthcare and trained over 8,000 community health workers in multiple countries. SPICE is a digital health platform embedded within health systems and government digital ecosystems, screening patients for various conditions and connecting them to care. Becoming open source allowed LABS to receive the designation as a Digital Public Good by a United Nations-endorsed initiative.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.47%
Tags
none
News

Medtronic reports second quarter fiscal 2024 financial results

Rhea-AI Summary
Medtronic plc (MDT) reported a 5.3% revenue growth in Q2 of fiscal year 2024, reaching $8.0 billion. The company raised its fiscal year guidance for organic revenue growth and EPS. They received U.S. FDA approval for innovative products and witnessed strong performance across multiple businesses and geographies.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.6%
Tags
earnings

FAQ

What is the current stock price of Medtronic plc (MDT)?

The current stock price of Medtronic plc (MDT) is $87.84 as of January 22, 2025.

What is the market cap of Medtronic plc (MDT)?

The market cap of Medtronic plc (MDT) is approximately 113.1B.

What does Medtronic plc specialize in?

Medtronic specializes in developing and manufacturing therapeutic medical devices for chronic diseases, including pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools.

Where are Medtronic’s headquarters located?

Medtronic’s operational and executive headquarters are in Minneapolis, Minnesota, while its legal headquarters are in Dublin, Ireland, following its acquisition of Covidien in 2015.

How significant are Medtronic’s international sales?

International sales account for roughly 50% of Medtronic’s total revenue.

What recent advancements has Medtronic made in AI for healthcare?

Medtronic recently launched the ColonPRO™ software for the GI Genius™ intelligent endoscopy system, enhancing AI-driven polyp detection and procedural highlights. The company also partnered with Modernizing Medicine® to integrate AI data with EHR systems.

What are Medtronic’s recent financial achievements?

Medtronic reported a global revenue of $32.364 billion for fiscal year 2024, a 3.6% increase from the previous year, driven by growth in its Cardiovascular, Neuroscience, Medical Surgical, and Diabetes portfolios.

What new technology has Medtronic introduced for chronic pain treatment?

Medtronic introduced the Inceptiv™ closed-loop rechargeable spinal cord stimulator (SCS), which the U.S. FDA approved for the treatment of chronic pain.

How many employees does Medtronic have worldwide?

Medtronic has a global team of over 95,000 employees across 150 countries.

What is Medtronic’s mission?

Medtronic's mission is to alleviate pain, restore health, and extend life.

Where can I find more information about Medtronic?

For more information about Medtronic, visit their official website at Medtronic.com.

How does Medtronic approach innovation in healthcare?

Medtronic leverages its diverse knowledge, insatiable curiosity, and commitment to helping those in need to deliver innovative technologies that transform lives, focusing on engineering extraordinary healthcare solutions.
Stock MDT logo
Medtronic plc

NYSE:MDT

MDT Rankings

#112 Ranked by Market Cap
#1008 Ranked by Dividends

MDT Stock Data

113.15B
1.28B
0.26%
85.42%
0.79%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States of America
GALWAY